All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Camila Morrone in ...

The University of Houston System's general counsel defended the dual course reviews underway across UH campuses on Thursday, telling the Board of Regents that top administrators chose an approach that ...

Bottom Line: Why Choose UWorld? After spending time inside the platform, UWorld feels the most dialed in for serious ACT repetition and mistake analysis. It keeps everything centered on practice ...

Inland Northwest golfers can start retrieving their clubs from winter storage. Spokane County Parks, Recreation and Golf intends to open its three county-owned courses in the coming weeks, following a ...

The Food and Drug Administration reversed an earlier decision to not review Moderna's flu vaccine and will evaluate the company's modified application for a potential approval, Moderna said on Feb. 18 ...

Beckoning audiences on a whimsical jaunt to always look on the bright side of life, the touring revival of “Spamalot” is especially winning for its unabashed determination to deliver on all manners of ...

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...

Moderna said the Food and Drug Administration has agreed to review its experimental mRNA flu shot, reversing an earlier decision to refuse to accept the application. The FDA is slated to make a ...

University of Houston professors could soon be required to self-evaluate their curricula to ensure that course material doesn't promote "personal or institutional advocacy." The five-page proposed ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. The SE exam is a PE exam ...

The US Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the pharmaceutical company said Wednesday. About two weeks ago, the FDA sent Moderna a ...

Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology. By Christina Jewett and ...